Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment duration and reason for final cessation of everolimus treatment in the RCC group
| AKI group | Non-AKI group | P-value | |
|---|---|---|---|
| Treatment duration (weeks) | 18 (9, 35) | 20 (12, 36) | NS |
| Total dose (mg) | 1050 (615, 1913) | 1173 (683, 1915) | NS |
| Discontinuation of drug | 15 (71%) | 53 (74%) | NS |
| Reason for discontinuation | NS | ||
| Disease progression | 10 (67%) | 35 (66%) | |
| Adverse effect | 2 (13%) | 9 (17%) | |
| Self-withdrawal | 3 (20%) | 9 (17%) |
RCC, renal cell carcinoma; AKI, acute kidney injury; NS, not significant.
